Nerlynx (neratinib)

pCPA File Number: 21178
Negotiation Status:
Negotiations were not pursued
Indication(s):
Hormone Receptor-Positive Breast Cancer
Sponsor/Manufacturer:
Knight Therapeutics Inc.
CDA-AMC Project Number:
PC0172-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: